OmniAb (OABI) Short term Debt (2021 - 2026)
OmniAb (OABI) reported Short term Debt of $1.0 million for Q1 2026, up 183.85% year-over-year from $353000.0 in Q1 2025, and down 4.02% quarter-over-quarter from $1.0 million in Q4 2025.
OmniAb (OABI) Short term Debt (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Short term Debt data on file, last reported at $1.0 million in Q1 2026.
- Short term Debt for Q1 2026 came in at $1.0 million, up 183.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 183.85% YoY), and the FY2025 annual result was $1.0 million, up 96.61% from the prior year.
- Short term Debt fell to $1.0 million in Q1 2026 per OABI's latest filing, from $1.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $4.0 million in Q4 2022 and troughed at $42631.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $891000.0 in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2022 and 2024: Short term Debt soared 1153220.0% in 2022, then tumbled 88.33% in 2024.
- A 5-year view of Short term Debt shows it stood at $4.0 million in 2022, then plunged by 67.6% to $1.3 million in 2023, then sank by 59.25% to $531000.0 in 2024, then surged by 96.61% to $1.0 million in 2025, then retreated by 4.02% to $1.0 million in 2026.
- Business Quant data shows OABI's Short term Debt at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $719000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | OmniAb | 293.04 Mn | 250.07 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 719,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 353,000.00 |
| Dec 31, 2024 | 531,000.00 |
| Sep 30, 2024 | 510,000.00 |
| Jun 30, 2024 | 328,000.00 |
| Mar 31, 2024 | 891,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 88,294.00 |
| Jun 30, 2022 | 57,666.00 |
| Mar 31, 2022 | 42,631.00 |
| Dec 31, 2021 | 2.54 Mn |
| Jun 30, 2021 | 5.00 |